MedPath

A comparative study of â??alternate dayâ?? versus â??dailyâ?? of oral iron tablets in pregnant women with mild anemia

Not Applicable
Conditions
Health Condition 1: D50- Iron deficiency anemia
Registration Number
CTRI/2019/12/022448
Lead Sponsor
CMC vellore
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

i.Pregnant women between 12 to 24 weeks

ii.Hemoglobin 10.0 to 10.9

iii.People consenting for the study

Exclusion Criteria

Exclusion Criteria:

a)High risk pregnancies

i.Multiple gestations,

ii.severe anaemia

iii.anaemia with failure

iv.risk of preterm delivery

b)Medical disorders

i.hematological disorders

ii.renal disorders

iii.chronic infections

c)criteria related to iron absorption

i.intolerance to oral iron

ii.recent blood transfusions in past 30 days

iii.Parental therapy

iv.Irritable bowel syndrome

v.Bariatric surgeries

d) people who are not consenting for the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Hemoglobin from baseline to 8 weeks later.Timepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
1.Change in serum ferritin from baseline to post baseline (after 8 weeks) <br/ ><br>2.Differences in gastrointestinal side effects <br/ ><br>3.Differences in compliance <br/ ><br>4.Differences in patient satisfaction <br/ ><br>Timepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath